3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Surgery
1
Stress, Psychological
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Seminoma
1
Sarcoma
1
Recurrence
1
Postoperative Complications
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer
1
Multiple Myeloma
1
Medulloblastoma
1
Lung Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Intermittent Fasting
1
Head and Neck Neoplasms
1
HER2-positive Breast Cancer
1
Esophageal Squamous Cell Carcinoma
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Interventions
Cyclophosphamide
48
fludarabine
32
Methotrexate
24
blinatumomab
20
fludarabine phosphate
19
Dexamethasone
19
Vincristine
18
Whole-Body Irradiation
16
Specimen Handling
16
Cytarabine
16
Tacrolimus
14
Mycophenolic Acid
14
Peripheral Blood Stem Cell Transplantation
13
Melphalan
13
Mercaptopurine
12
Calcium Dobesilate
12
merphos
11
Busulfan
11
Biopsy
11
Magnetic Resonance Spectroscopy
10
Etoposide
10
Stem Cell Transplantation
9
Prednisone
9
Granulocyte Colony-Stimulating Factor
9
Cyclosporine
9
Thiotepa
8
Rituximab
8
Mesna
8
Filgrastim
8
Doxorubicin
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Neoadjuvant Therapy
×
90 days
×
Clear all
No trials found.